Steve Miller sold $2.3M of Catalyst Pharmaceuticals (CPRX)

Executed Aug 26 2025, disclosed Aug 28 2025, 2 days later.

Value, as filed

$2.3M

115,000 sh × $20.28

Executed

Aug 26 2025

the trade date, as filed

Disclosed

Aug 28 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SM Steve Miller Chief Op. & Scientific Officer profile →

Steve Miller (Chief Op. & Scientific Officer) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in CPRX. The largest single filing was $2.3M of CPRX (115,000 sh × $20.28, as filed), executed Aug 26 2025.

The name

CPRX CPRX CPRX · 20 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Steve Miller in CPRX

CPRXSALE CATALYST PHARMACEUTICALS, INC. $1.1M
50,000 sh × $21.93
Exec Dec 10 2024
Filed Dec 11 2024 · 5:30 PM ET